Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuclear Galectin-1 Drives Cancer Progression through <i>O</i>-GlcNAcylation-Dependent Regulation of SOX2.

International journal of biological sciences·2026
Same author

The Gwangju Alzheimer's & Related Dementias (GARD) cohort: Over a decade of Asia's largest longitudinal multimodal study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Genetic architecture of human aging and longevity: Insights from genome-wide association studies.

BMB reports·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Adenylate kinase 5, a novel genetic risk factor for Alzheimer's disease, regulates microglial inflammatory activation.

Molecular brain·2025
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Cardiovascular-kidney-metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Changes in DNA methylation-based aging predicts brain damage and dementia and reflects life-course cardiovascular risk.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Hyeonseul Park1, Jungsoo Gim2,3,4

  • 1BK21 FOUR, Department of Integrative Biological Sciences, Chosun University, Gwangju, Gwangju Metropolitan City, Korea, Republic of (South).

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 26, 2025
PubMed
Summary
This summary is machine-generated.

This study reveals key sleep differences in Alzheimer's patients using wearable devices. Specific sleep metrics effectively distinguish between healthy, mild cognitive impairment, and dementia groups.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Area of Science:

  • Neuroscience
  • Gerontology
  • Sleep Medicine

Background:

  • Aging is associated with changes in sleep patterns, including reduced non-rapid eye movement (NREM) sleep and slow-wave activity (SWA).
  • Sleep fragmentation and increased arousals in Alzheimer's disease (AD) correlate with cognitive decline, but underlying mechanisms and accurate sleep measurement remain challenging.
  • Reliable sleep data collection is crucial for understanding age-related sleep changes and their impact on neurodegenerative diseases.

Purpose of the Study:

  • To generate high-quality sleep data from a large Alzheimer's cohort using wearable technology.
  • To analyze sleep characteristics and identify differences across various cognitive statuses, including healthy controls, mild cognitive impairment (MCI), and Alzheimer's disease (AD).
  • To determine specific sleep parameters that can effectively differentiate between these cognitive groups.

Main Methods:

  • Utilized the second-generation OURA ring to collect over 35 sleep-related variables from 299 participants in the Gwangju Alzheimer's and Related Dementias (GARD) cohort.
  • Data collection spanned 79 days per participant, excluding the initial two days, ensuring robust sleep records.
  • Employed statistical analyses to compare sleep characteristics across groups with confirmed diagnoses and neuropsychological assessments.

Main Results:

  • Significant differences in sleep characteristics were observed across diagnostic groups, particularly in the dementia group.
  • Two specific sleep parameters emerged as key indicators, effectively differentiating between the Healthy Cognitive (HC) and Mild Cognitive Impairment (MCI) groups.
  • Detailed analysis of sleep stages and dynamics revealed distinct sleep patterns unique to each cognitive group.

Conclusions:

  • The study successfully identified significant variations in sleep characteristics among different cognitive groups, including dementia patients.
  • Key sleep parameters demonstrated high efficacy in distinguishing between cognitive statuses.
  • Further insights into group-specific sleep dynamics underscore the importance of sleep analysis in understanding cognitive decline.